This is a working overview of thymus extract, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2026-03-03 and is reviewed periodically as new material appears.
Quality control for thymosin alpha-1 focuses on identity, purity, and potency. Identity is confirmed by mass spectrometry and amino acid analysis, while purity is assessed by chromatography with limits on related substances and residual solvents. Potency assays may use cell-based immune readouts, but these are not standardized across laboratories. Regulatory status differs by jurisdiction; no product is approved in the United States for clinical use, whereas some other countries register injectable forms for specific indications.
Quantifying thymosin alpha-1 in a sample usually relies on reverse-phase high-performance liquid chromatography. The peptide lacks strong chromophores, so detection often occurs at 214 nm, where the peptide backbone absorbs. Mass spectrometry provides confirmatory identification and can detect sequence variants or truncations. Immunoassays have been used in biological matrices, but they may cross-react with related fragments. For purity assessment, chromatographic peak area gives the main component percentage, while mass accuracy verifies molecular identity.
The lyophilized peptide is generally stable for extended periods when kept cold and dry. Once dissolved, aqueous solutions are less stable; hydrolysis, oxidation, and aggregation can degrade the material. Storage at -20 °C or lower slows these processes. Repeated freeze-thaw cycles are best avoided because they can promote aggregation. The exact shelf life depends on formulation, pH, and concentration, so stability studies are typically performed for each specific product.
The peptide was described in the 1970s as a component of thymic extracts, and early research focused on restoring immune function in immunodeficiency states. A synthetic version entered clinical development in the 1980s and is approved as a drug in several countries for conditions such as chronic hepatitis B and certain immunodeficiencies. Approval status varies widely by jurisdiction, and in the United States it is not an approved therapeutic. Regulatory and clinical positions differ, so statements about efficacy should be tied to specific indications and studies.
Thymosin alpha-1 is a synthetic peptide of 28 amino acids, corresponding to the N-terminal fragment of prothymosin alpha. Its sequence begins with acetylation at the N-terminus, a modification that affects stability and receptor interaction. The peptide is acidic, with a calculated isoelectric point near 4.2, and carries no disulfide bonds, so its secondary structure is largely flexible in solution. Molecular mass is approximately 3108 daltons. The native form was first isolated from bovine thymus tissue, while pharmaceutical material is produced by solid-phase peptide synthesis.
Within the immune system, the peptide acts on several cell types rather than a single target. Reported activities include promotion of T-cell maturation, enhancement of natural killer cell activity, and modulation of cytokine production by dendritic cells and macrophages. Some of these effects appear to operate through toll-like receptor signaling, though the precise receptor-level mechanism remains debated. Whether the observed immune changes translate into clinical benefit is a separate question and depends on the indication studied.
| Property | Value | Notes |
|---|---|---|
| Detection wavelength | 214 nm | Peptide bond absorption; 280 nm is not useful. |
| Confirmatory method | Electrospray mass spectrometry | Verifies mass near 3108 Da. |
| Solution stability | Limited at room temperature | Aqueous solutions degrade faster than powder. |
| Recommended storage | -20 °C | For lyophilized powder; protect from moisture. |
| Purity criterion | ≥95% by RP-HPLC | Typical research-grade specification. |
{\displaystyle n_{\mathrm {A} }=n_{\mathrm {B} }{\frac {R_{\mathrm {B} }-R_{\mathrm {AB} }}{R_{\mathrm {AB} }-R_{\mathrm {A} }}}\times {\frac {x(^{j}\mathrm {A} )_{\mathrm {B} }}{x(^{j}\mathrm {A} )_{\mathrm {A} }}}}
Ulotaront (INNTooltip International Nonproprietary Name; developmental codes SEP-363856, SEP-856) is an investigational antipsychotic that is undergoing clinical trials for the treatment of schizophrenia and Parkinson's disease psychosis. The medication was discovered in collaboration between PsychoGenics Inc. and Sunovion Pharmaceuticals (which was subsequently merged into Sumitomo Pharma) using PsychoGenics' behavior and AI-based phenotypic drug discovery platform, SmartCube. Ulotaront is in phase III clinical trial for schizophrenia, phase II/III for generalized anxiety disorder and major depressive disorder, and discontinued for narcolepsy and psychotic disorders. Research has shown that ulotaront results in a greater reduction from baseline in the PANSS total score than placebo. Treatment with ulotaront, as compared with placebo, was also associated with an improvement in sleep quality. Ulotaront was awarded a Breakthrough Therapy designation due to its increased efficacy and greatly reduced side effects compared to current treatments.
=== The New York Times === On April 2, 2023, the main account for The New York Times became one of the first major media companies to lose its verified status on Twitter. Ahead of the official release of Verification for Organizations, newspaper The New York Times stated that it would not pay for a verification checkmark. In response to a Twitter user who pointed out the newspaper's decision, Musk stated, "Oh ok, we'll take it off then". Musk then called The New York Times hypocritical for charging readers to read its articles. He criticised the newspaper for tweeting hundreds of posts every day, including drafts that were not accepted into the published editions of the paper, and inundating the daily feed of users who followed it. Despite the deadline for Twitter Blue passing, and aside from The New York Times, many legacy verified accounts continued to retain their verified status. According to The New York Times themselves, the top 10,000 Twitter accounts and top 500 advertisers would be exempt from paying.
The 43-second "Iron Gland" was developed out of a guitar riff that Cantrell would play that annoyed the other band members, so he created the song (adding in a reference to Black Sabbath's "Iron Man") and promised to never play the guitar riff again. It features Tom Araya of thrash metal band Slayer on vocals, as well as Layne Staley. "Hate to Feel" and "Angry Chair" were both composed solely by Staley, who also played guitar on both tracks, and Cantrell has expressed his pride in seeing Staley grow as a songwriter and guitarist. "Down in a Hole" was written by Cantrell to his long-time girlfriend, Courtney Clarke. Cantrell explained the song in the liner notes of 1999's Music Bank box set: "["Down in a Hole"]'s in my top three, personally. It's to my long-time love. It's the reality of my life, the path I've chosen and in a weird way it kind of foretold where we are right now. It's hard for us to both understand... that this life is not conducive to much success with long-term relationships." The album's final track, "Would?", was written by Cantrell as a tribute to his friend and late lead singer of Mother Love Bone, Andrew Wood, who died of a drug overdose in 1990. Cantrell said the song is also "directed towards people who pass judgments."
== Further reading == Biot, René. (1962). The Enigma of the Stigmata. Hawthorn Books. Carroll, Robert Todd. (2003). Stigmata. In The Skeptic's Dictionary. Wiley. ISBN 978-0-471-27242-7 Harrison, Ted. (1994). Stigmata: A Medieval Phenomenon in a Modern Age. St Martins Press. ISBN 0-312-11372-2 Mazzoni, Cristina. (1996). Saint Hysteria: Neurosis, Mysticism, and Gender in European Culture. Cornell University Press. ISBN 0-8014-3229-4 Nickell, Joe. (1993). Looking for a Miracle: Weeping Icons, Relics, Stigmata, Visions & Healing Cures. Prometheus Books. ISBN 1-57392-680-9 Radford, Benjamin. (2014). What is Stigmata?. LiveScience. Retrieved 12 May 2016. Wilson, Ian. (1988). The Bleeding Mind: An Investigation into the Mysterious Phenomena of Stigmata. Weidenfeld & Nicolson. ISBN 0-297-79099-4 Yarom, Nitza. (1992). Body, Blood, and Sexuality: A Psychoanalytic Study of St. Francis' Stigmata and Their Historical Context. Peter Lang Publisher. Van Osselaer, Tina; Graus, Andrea; Rossi, Leonardo; Smeyers, Kristof (12 October 2020). The Devotion and Promotion of Stigmatics in Europe c. 1800–1950, between Saints and Celebrities (PDF). Numen Book Series-Studies in the History of Religions. Vol. 167. Leiden, Boston: Brill. p. 487. ISBN 978-90-04-43935-1. ISSN 0169-8834. LCCN 2020031449. Archived (PDF) from the original on September 9, 2021.
Sources: en.wikipedia.org
Early researchers found that an electric or magnetic field could split radioactive emissions into three types of beams. Ernest Rutherford named the three types alpha, beta, and gamma, in increasing order of their ability to penetrate matter. Alpha decay is observed only in heavier elements of atomic number 52 (tellurium) and greater, with the exception of beryllium-8 (which decays to two alpha particles). Gamma rays are emitted from excited states of nuclei as a side effect of alpha or beta decay. Beta decay is the only type to be observed in all the elements. Lead, atomic number 82, is the heaviest element to have any isotopes stable (to the limit of measurement) to radioactive decay. Radioactive decay is seen in all isotopes of all elements of atomic number 83 (bismuth) or greater. Bismuth-209, however, is only very slightly radioactive, with a half-life greater than the age of the universe by ten orders of magnitude; radioisotopes with extremely long half-lives are considered effectively stable for practical purposes. In analyzing the nature of the decay products, it was obvious from the direction of the electromagnetic forces applied to the radiations by external magnetic and electric fields that alpha particles carried a positive charge, beta particles carried a negative charge, and gamma rays were neutral. From the magnitude of deflection, it was clear that alpha particles were much more massive than beta particles.
Ethylene oxide is one of the most important raw materials used in large-scale chemical production. Most ethylene oxide is used for synthesis of ethylene glycols, including diethylene glycol and triethylene glycol, that accounts for up to 75% of global consumption. Other important products include ethylene glycol ethers, ethanolamines, and ethoxylates. Among glycols, ethylene glycol is used as antifreeze, in the production of polyester and polyethylene terephthalate (PET – raw material for plastic bottles), liquid coolants, and solvents.
== Applications in biomedical research == LifeAct peptides have been used as a universal marker for F-actin visualization in biomedical research. An experiment conducted by Sawant et al. utilized LifeAct GFP to visualize the migration of control border cells in the ovaries of Drosophila flies, in order to determine how cells move in terms of small and large collectives during development and cancer. Lifeact labels F-actin in border cells and adjacent follicle cells allowed for the detailed examination of border cell membranes and protrusions. Studies regarding the degradation of actin cytoskeleton due to aging relied on LifeAct for the analysis of cytoskeletal organization as a function of age. Transgenic lines that expressed the LifeAct in various tissues of C. elegans were primarily used for imaging.
== Epidemiology == In a study in British Columbia, the overall incidence of the inborn errors of metabolism were estimated to be 40 per 100,000 live births or 1 in 2,500 births, overall representing more than approximately 15% of single gene disorders in the population. While a Mexican study established an overall incidence of 3.4:1,000 live newborns and a carrier detection of 6.8:1,000 NBS.
Alex Browne (born 9 August 1992) is a former professional Australian rules footballer who played for the Essendon Football Club in the Australian Football League (AFL). Browne played for the Oakleigh Chargers in the TAC Cup. He was drafted by Essendon with pick 48 in the 2010 national draft and made his debut against Melbourne at the Melbourne Cricket Ground in round 11 of the 2011 AFL season. He was delisted in October 2015. His father, Murray Browne, played for Collingwood and Fitzroy in the 1980s and his mother was a cheerleader for Carlton. Browne, along with 33 other Essendon players, was found guilty of using a banned performance-enhancing substance, thymosin beta-4, as part of Essendon's sports supplements program during the 2012 season. He and his teammates were initially found not guilty in March 2015 by the AFL Anti-Doping Tribunal, but a guilty verdict was returned in January 2016 after an appeal by the World Anti-Doping Agency. He was suspended for two years which, with backdating, ended in November 2016; as a result, he served approximately fourteen months of his suspension. Browne had signed for the Northern Blues in the Victorian Football League for the 2016 season before his suspension ended his 2016 season.
Sources: en.wikipedia.org
The presidency of Ronald Reagan (1981–89) saw a significant increase in federal focus on drug interdiction and prosecution. Shortly after his inauguration, Reagan announced, "We're taking down the surrender flag that has flown over so many drug efforts; we're running up a battle flag." From 1980 to 1984, the annual budget of the Federal Bureau of Investigation (FBI) drug enforcement units went from $8 million to $95 million. In 1982, Vice President George H. W. Bush and his aides began pushing for the involvement of the Central Intelligence Agency (CIA) and the US military in drug interdiction efforts. Early in the Reagan term, First Lady Nancy Reagan, with the help of an advertising agency, began her youth-oriented "Just Say No" anti-drug campaign. Propelled by the First Lady's tireless promotional efforts through the 1980s, "Just Say No" entered the American vernacular. Later research found that the campaign had little or no impact on youth drug use. One striking change attributed to the effort: public perception of drug abuse as America's most serious problem, in the 2–6% range in 1985, rose to 64% in 1989. In January 1982, Reagan established the South Florida Task Force, chaired by Bush, targeting a surge of cocaine and cannabis entering through the Miami region, and the sharp rise in related crime. The project involved the DEA, the Customs Service, the FBI and other agencies, and Armed Forces ships and planes. It was called the "most ambitious and expensive drug enforcement operation" in US history; critics called it an election year political stunt.
van Krevelen, D.W. (1950). "Graphical-statistical method for the study of structure and reaction processes of coal", Fuel, 29, 269–84. van Krevelen, D.W. and Schuyer, J. (1957) Coal science. Elsevier publishing company. The chemistry and technology of petroleum
A banana bag (or rally pack) is a bag of IV fluids containing vitamins and minerals. The bags typically contain thiamine, folic acid, and magnesium sulfate, and are usually used to correct nutritional deficiencies or electrolyte imbalances in the human body. The solution has a yellow color, hence the term "banana bag".
== Nutritional sources == Myo-inositol is naturally present in a variety of foods, although tables of food composition do not always distinguish between lecithin, the relatively bioavailable lipid form and the biounavailable phytate/phosphate form. Foods containing the highest concentrations of myo-inositol and its compounds include fruits, beans, grains, and nuts. Fruits in particular, especially oranges and cantaloupe, contain the highest amounts of myo-inositol. It is also present in beans, nuts, and grains, however, these contain large amounts of myo-inositol in the phytate form, which is not bioavailable without transformation by phytase enzymes. Bacillus subtilis, the microorganism which produces the fermented food natto, produces phytase enzymes that may convert phytic acid to a more bioavailable form of inositol polyphosphate in the gut. Additionally, Bacteroides species in the gut secrete vesicles containing an active enzyme which converts the phytate molecule into bioavailable phosphorus and inositol polyphosphate, which is an important signaling molecule in the human body. Myo-inositol can also be found as an ingredient in energy drinks, either in conjunction with or as a substitute for glucose. In humans, myo-inositol is naturally made from glucose-6-phosphate through enzymatic dephosphorylation.
Sources: en.wikipedia.org
Reverse-phase HPLC with ultraviolet detection at 214 nm is common. Mass spectrometry is used to confirm molecular identity and detect modifications. Immunoassays exist but may not distinguish the intact peptide from fragments.
The lyophilized powder is usually stored at -20 °C or below. Dissolved solutions are less stable and should be prepared fresh when possible. Freeze-thaw cycling can reduce integrity.
It lacks aromatic residues, so it does not absorb strongly at 280 nm. Its negative charge and hydrophilic nature can affect chromatographic retention. These properties require method development for reliable separation.
It corresponds to a fragment of the larger protein prothymosin alpha, which is present in many tissues. The isolated 28-amino-acid peptide was originally obtained from thymus preparations, and the pharmaceutical product is synthesized rather than extracted. The term therefore describes both a natural fragment and a manufactured drug substance.